301 related articles for article (PubMed ID: 28987439)
1. Evaluation of T and B memory cell responses elicited by the pandemic H1N1 vaccine in HIV-infected and HIV-uninfected individuals.
Sun P; Crum-Cianflone NF; Defang G; Williams M; Ganesan A; Agan BK; Lalani T; Whitman T; Brandt C; Burgess TH
Vaccine; 2017 Oct; 35(45):6103-6111. PubMed ID: 28987439
[TBL] [Abstract][Full Text] [Related]
2. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.
Weinberg A; Muresan P; Richardson KM; Fenton T; Dominguez T; Bloom A; Watts DH; Abzug MJ; Nachman SA; Levin MJ;
PLoS One; 2015; 10(4):e0122431. PubMed ID: 25874544
[TBL] [Abstract][Full Text] [Related]
3. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination.
Subbramanian RA; Basha S; Shata MT; Brady RC; Bernstein DI
Vaccine; 2010 Dec; 28(52):8258-67. PubMed ID: 21050903
[TBL] [Abstract][Full Text] [Related]
4. Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.
Chen GL; Lau YF; Lamirande EW; McCall AW; Subbarao K
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1140-5. PubMed ID: 21199945
[TBL] [Abstract][Full Text] [Related]
5. Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
Soonawala D; Rimmelzwaan GF; Gelinck LB; Visser LG; Kroon FP
PLoS One; 2011 Jan; 6(1):e16496. PubMed ID: 21304982
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.
Cortina-Ceballos B; Godoy-Lozano EE; Téllez-Sosa J; Ovilla-Muñoz M; Sámano-Sánchez H; Aguilar-Salgado A; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Aparicio-Antonio R; Rodríguez MH; Martínez-Barnetche J
Genome Med; 2015 Nov; 7():124. PubMed ID: 26608341
[TBL] [Abstract][Full Text] [Related]
7. Possible Impact of Yearly Childhood Vaccination With Trivalent Inactivated Influenza Vaccine (TIV) on the Immune Response to the Pandemic Strain H1N1.
Amer A; Fischer H; Li X; Asmar B
Clin Pediatr (Phila); 2016 Mar; 55(3):245-50. PubMed ID: 26159622
[TBL] [Abstract][Full Text] [Related]
8. T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.
Weinberg A; Song LY; Fenton T; Nachman SA; Read JS; Patterson-Bartlett J; Levin MJ
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):51-9. PubMed ID: 20059397
[TBL] [Abstract][Full Text] [Related]
9. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
[TBL] [Abstract][Full Text] [Related]
12. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong: a randomized controlled trial.
Cowling BJ; Ng S; Ma ES; Fang VJ; So HC; Wai W; Cheng CK; Wong JY; Chan KH; Ip DK; Chiu SS; Peiris JS; Leung GM
Clin Infect Dis; 2012 Sep; 55(5):695-702. PubMed ID: 22670050
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
Lambe T; Spencer AJ; Mullarkey CE; Antrobus RD; Yu LM; de Whalley P; Thompson BA; Jones C; Chalk J; Kerridge S; Hill AV; Snape MD; Pollard AJ; Gilbert SC
Pediatr Infect Dis J; 2012 Jun; 31(6):e86-91. PubMed ID: 22466328
[TBL] [Abstract][Full Text] [Related]
14. Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.
Cao RG; Suarez NM; Obermoser G; Lopez SM; Flano E; Mertz SE; Albrecht RA; García-Sastre A; Mejias A; Xu H; Qin H; Blankenship D; Palucka K; Pascual V; Ramilo O
J Infect Dis; 2014 Jul; 210(2):224-33. PubMed ID: 24495909
[TBL] [Abstract][Full Text] [Related]
15. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer.
Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM
J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042
[TBL] [Abstract][Full Text] [Related]
17. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
[TBL] [Abstract][Full Text] [Related]
19. T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.
Li J; Arévalo MT; Chen Y; Chen S; Zeng M
Int J Infect Dis; 2014 Oct; 27():37-43. PubMed ID: 25172265
[TBL] [Abstract][Full Text] [Related]
20. Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.
Kristensen AB; Lay WN; Ana-Sosa-Batiz F; Vanderven HA; Madhavi V; Laurie KL; Carolan L; Wines BD; Hogarth M; Wheatley AK; Kent SJ
J Virol; 2016 Jun; 90(12):5724-5734. PubMed ID: 27053553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
